Literature DB >> 16690170

A phosphonamidate containing aromatic N-terminal amino group as inhibitor of leucine aminopeptidase-design, synthesis and stability.

A Mucha1, A Kunert, J Grembecka, M Pawełczak, P Kafarski.   

Abstract

Fully deprotected phosphonamidate dipeptides, predicted as effective inhibitors of cytosolic leucine aminopeptidase, showed unexpected instability in water solution at pH below 12. Their hydrolysis rate was strictly correlated with basicity of the N-terminal amino group. To improve this feature a phosphonamidate analogue containing less basic, aromatic 2-aminophenylphosphonate residue in P1 position of the inhibitor was designed. The target compound was synthesised starting from diethyl 2-nitrophosphonate in several step procedure. The decrease in basicity of the terminal amino moiety of the modified analogue in fact resulted in satisfactory improvement of hydrolytic stability of the P-N bond. The developed phosphonamidate was proved to be fully resistant to hydrolysis above pH 7. Surprisingly, tested in enzymatic assays towards leucine aminopeptidase (optimum pH 8.5), it did not exhibit inhibition activity up to milimolar concentration. The explanation could be that diminishing the basic character of the terminal amino group may result in a change of its affinity towards the zinc ions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690170     DOI: 10.1016/j.ejmech.2006.03.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.

Authors:  Yunjun Guo; Riccardo Ferdani; Carolyn J Anderson
Journal:  Bioconjug Chem       Date:  2012-06-18       Impact factor: 4.774

2.  Colloidal Confinement of Polyphosphate on Gold Nanoparticles Robustly Activates the Contact Pathway of Blood Coagulation.

Authors:  Magdalena Szymusiak; Alexander J Donovan; Stephanie A Smith; Ross Ransom; Hao Shen; Joseph Kalkowski; James H Morrissey; Ying Liu
Journal:  Bioconjug Chem       Date:  2015-12-15       Impact factor: 4.774

3.  Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice.

Authors:  Dexing Zeng; Yunjun Guo; Alexander G White; Zhengxin Cai; Jalpa Modi; Riccardo Ferdani; Carolyn J Anderson
Journal:  Mol Pharm       Date:  2014-04-25       Impact factor: 4.939

4.  Phosphinotripeptidic Inhibitors of Leucylaminopeptidases.

Authors:  Michał Jewgiński; Kinga Haremza; Jesús M de Los Santos; Zouhair Es Sbai; Bartosz Oszywa; Małgorzata Pawełczak; Francisco Palacios; Rafał Latajka
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.